Centrum Medyczne w Łańcucie
- Address
- Ul. Ignacego Paderewskiego 5, 37-100 Lancut, Poland
Centrum Medyczne W Lancucie - Infectious Disease Research Center
Centrum Medyczne W Lancucie is a specialized clinical research facility with extensive expertise in infectious disease therapeutics, particularly focusing on chronic viral infections. The center plays a crucial role in advancing treatment options for patients with complex viral conditions through participation in international Phase 3 clinical trials and long-term follow-up studies.
- Chronic Hepatitis B functional cure research, including novel anti-sense oligonucleotide therapies and targeted immunotherapy approaches
- Investigation of bepirovirsen treatment protocols in nucleos(t)ide analogue-treated patients with varying disease profiles
- Long-term durability assessment of hepatitis B treatment responses and functional cure maintenance
- Severe viral lung infection management with innovative monoclonal antibody therapies
The center demonstrates particular strength in hepatitis B virus (HBV) research, conducting comprehensive studies that evaluate both immediate treatment efficacy and extended durability of therapeutic responses. Their research portfolio includes evaluation of sequential combination therapies, assessment of functional cure achievement in chronic HBV patients, and investigation of novel biological agents for severe respiratory viral infections requiring supplemental oxygen support.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1AstraZeneca AB1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Medyczne w Łańcucie
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Randomized, Open-Label Active Controlled Study Evaluating the Safety and Efficacy of oral VH4524184 Coadministered with Emtricitabine and Tenofovir Alafenamide in Treatment Naïve Viremic Persons with HIV-1.( INNOVATE Study) | Viiv Healthcare UK Limited | Phase II | Recruiting | Feb 2026 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bepirovirsen | 3 | Unknown | 2019-03-28 | 2023-01-09 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.